# A Study of Carbon-14-Labeled [14C]-LY3549492 in Healthy Participants

> **NCT06194500** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 18 (actual)

## Conditions studied

- Healthy Male

## Interventions

- **DRUG:** [14C]-LY3549492
- **DRUG:** LY3549492
- **DRUG:** [14C]-LY3549492

## Key facts

- **NCT ID:** NCT06194500
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-03
- **Primary completion:** 2024-02-15
- **Final completion:** 2024-02-15
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06194500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06194500, "A Study of Carbon-14-Labeled [14C]-LY3549492 in Healthy Participants". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT06194500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*